Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating a combination of drugs considered standard treatment for
children and young adults with acute lymphoblastic leukemia (ALL), in combination with a new
drug called MLN 9708. Additionally, the study is also evaluating if bone marrow or stem cell
transplantation, which will be given to some participants, helps to prevent ALL from
returning.